You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
重藥控股(000950.SZ):重藥惠生與惠生致誠等共設子基金 擬投資於醫療大健康領域相關企業
格隆匯 06-15 17:08

格隆匯 6 月 15日丨重藥控股(000950.SZ)公佈,近日,公司收到重藥惠生通知,根據發展需要,其與惠生致誠、自然人馮榮共同發起設立重慶重藥惠生致潤健康產業股權投資基金合夥企業(有限合夥)(“子基金”或“重藥惠生致潤”),子基金規模為3.01億元人民幣,擬投資於醫療大健康領域相關企業,重點投資醫療器械、IVD、醫療服務領域。截至目前,重藥惠生致潤已完成工商註冊登記手續,取得了由重慶市江北區市場監督管理局核發的營業執照,並按照《證券投資基金法》和《私募投資基金監督管理暫行辦法》等法律法規的要求,在中國證券投資基金業協會完成了備案手續,取得了《私募投資基金備案證明》。

新設立的子基金在後續投資運作中,存在一定的市場風險。同時也可能面臨宏觀經濟、政策法律、行業週期、監管政策等多方面影響帶來的不確定性風險。敬請廣大投資者謹慎決策,注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account